Cognigen

Cognigen Corporation is a leading provider of integrated drug analysis and support services, including pharmacokinetic and pharmacodynamic (PK/PD) modeling, statistical analysis, clinical trial simulation, and regulatory reporting — with a focus on dose selection and justification decision support. Headquartered in Buffalo, New York, Cognigen Corporation was co-founded in 1992 by Dr. Ted Grasela, PharmD, President and Chief Executive Officer; Cynthia Walawander, MA, PMP, Executive Vice President and Chief Operating Officer; and Jill Fiedler-Kelly, MS, Vice President of Pharmacometric Services and CSO.